2007 were mark-to-market gains of $314 million and $282 million,
respectively, related to Euro-denominated currency options related to the
acquisition of OBS.
5/ Special and acquisition-related charges relate to the Productivity
Transformation Program (PTP) which also incorporates the ongoing
integration of OBS. For the three and nine months ended September 30, 2008
these charges were $101 million ($93 million for severance costs and $8
million for integration-related costs) and $218 million, respectively.
Special and acquisition-related charges for the three and nine months
ended September 30, 2007 were $20 million and $32 million, respectively.
6/ Equity income for the three and nine months ended September 30, 2008
include $19 million and $83 million, respectively, of income related to
the termination of a respiratory joint venture with Merck.
Reconciliation from Reported Net Income Available to Common Shareholders and Reported Diluted Earnings Per Common Share to As Reconciled Amounts for Net Income
Available to Common Shareholders and Diluted Earnings per Common Share
(Amounts in Millions, except per share figures)
To supplement its consolidated financial statements presented in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP), Schering-Plough is providing the supplemental financial information below and on the following pages to reflect "As Reconciled" amounts related to Net income available to common shareholders and Diluted earnings per common share. "As Reconciled" amounts exclude the effects of purchase accounting adjustments, special and acquisition-related items and other specified items.
"As Reconciled" amounts related to Net income available to common
shareholders and Diluted earnings per common share are non-U.S. GAAP
measures used by
|SOURCE Schering-Plough Corporation|
Copyright©2008 PR Newswire.
All rights reserved